[HTML][HTML] Macrophage migration inhibitory factor (MIF): a promising biomarker

G Grieb, M Merk, J Bernhagen… - Drug news & …, 2010 - ncbi.nlm.nih.gov
Macrophage migration inhibitory (MIF) factor is an immunoregulatory cytokine whose effect
on arresting random immune cell movement was recognized several decades ago. Despite …

MIF and CD74-suitability as clinical biomarkers

G Grieb, BS Kim, D Simons… - Mini reviews in …, 2014 - ingentaconnect.com
Macrophage migration inhibitory factor (MIF) is a pleiotropic immunoregulatory cytokine
whose effects on arresting 'random'immune cell movement was already recognized decades …

[HTML][HTML] CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer

YX Zheng, M Yang, TT Rong, XL Yuan… - World journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To investigate the relationship and molecular features of CD74/macrophage migration
inhibitory factor (MIF)/Toll-like receptor 4 (TLR4) in gastric cancer. METHODS: CD74, MIF …

Identification of macrophage migration inhibitory factor and human neutrophil peptides 1–3 as potential biomarkers for gastric cancer

Y Mohri, T Mohri, W Wei, YJ Qi, A Martin, C Miki… - British journal of …, 2009 - nature.com
Background: Proteomic methods have the potential to meet the urgent need for better cancer
biomarkers. We have used a range of proteomic analyses of serum and tissue from gastric …

[HTML][HTML] Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway

GQ Li, J Xie, XY Lei, L Zhang - World Journal of Gastroenterology …, 2009 - ncbi.nlm.nih.gov
AIM: To investigate the effects of macrophage migration inhibitory factor (MIF) on
proliferation of human gastric cancer MGC-803 cells and expression of cyclin D1 and p27 …

Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies

N Kindt, J Preillon, H Kaltner, HJ Gabius… - Journal of cancer …, 2013 - Springer
Purpose The present in vivo/in vitro study was undertaken in order to evaluate the
importance of macrophage migration inhibitory factor (MIF) in the progression of head and …

Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers

KT Morris, RA Nofchissey, IV Pinchuk, EJ Beswick - PloS one, 2014 - journals.plos.org
Macrophage Migration Inhibitory Factor (MIF) is an inflammatory cytokine that is highly
produced in gastrointestinal cancers. Since chronic inflammation is a risk factor for …

Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma

MB De Souza, OA Curioni, JL Kanda… - Oncology …, 2014 - spandidos-publications.com
The overexpression of macrophage migration inhibitory factor (MIF) has been identified in a
variety of tumors and the investigation of its molecular mechanisms in tumor progression is a …

Macrophage migration inhibitory factor expression in cervical cancer

M Krockenberger, JB Engel, J Kolb… - Journal of cancer …, 2010 - Springer
Purpose The glycoprotein macrophage migration inhibitory factor (MIF) is a cytokine that has
been shown to promote tumor progression and tumor immune escape in ovarian cancer …

A role for NRAGE in NF-κB activation through the non-canonical BMP pathway

N Matluk, JA Rochira, A Karaczyn, T Adams, JM Verdi - BMC biology, 2010 - Springer
Background Previous studies have linked neurotrophin receptor-interacting MAGE protein to
the bone morphogenic protein signaling pathway and its effect on p38 mediated apoptosis …